Home Cart Sign in  
Chemical Structure| 870087-36-8 Chemical Structure| 870087-36-8

Structure of Apilimod mesylate
CAS No.: 870087-36-8

Chemical Structure| 870087-36-8
Product Citations

Alternative Products

Product Details of Apilimod mesylate

CAS No. :870087-36-8
Formula : C25H34N6O8S2
M.W : 610.70
SMILES Code : CC1=CC(/C=N/NC2=CC(N3CCOCC3)=NC(OCCC4=NC=CC=C4)=N2)=CC=C1.CS(=O)(O)=O.CS(=O)(O)=O
Synonyms :
STA 5326 mesylate; LAM-002A; AIT-101 mesylate
MDL No. :MFCD28167749
InChI Key :GAJWNIKZLYZYSY-OKUPSQOASA-N
Pubchem ID :11527330

Safety of Apilimod mesylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Apilimod mesylate

PI3K-AKT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Primary cardiac fibroblasts 100 nM 48 h Apilimod treatment almost completely abrogated collagen accumulation and pro-fibrotic transcript levels. PMC8120213
Caco-2 cells 2 h Apilimod combined with Camostat effectively suppresses viral entry and replication. PMC8844383
Vero E6 10 nM 1 h Apilimod strongly inhibited SARS-CoV-2 infection. PMC7456157

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice pressure overload-induced heart failure Intraperitoneal injection 2 mg/kg/day once daily for 4 weeks Apilimod reduced myocardial interstitial fibrosis development and prevented left ventricular dysfunction. PMC8120213

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT05483322 Frontotemporal Dementia NO_LONGER_AVAILABLE - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.64mL

0.33mL

0.16mL

8.19mL

1.64mL

0.82mL

16.37mL

3.27mL

1.64mL

References

 

Historical Records

Categories